Efficient fixation procedure of human leukemia cells in sulforhodamine B cytotoxicity assay

Journal of Pharmacological and Toxicological Methods

Volumn 36, Issue 3, 1996, Pages 163-169

  Kim, Hwan Mook ^a   Han, Sang Bae ^a   Kim, Moon Soon ^a   Kang, Jong Seong ^b   Oh, Goo Taeg ^a   Hong, Dong Ho ^a  

^a Korea Institute of Science and Technology   (South Korea)

^b Chungnam National University   (South Korea)

Author keywords

Cytotoxicity; Leukemias; SRB assay; TCA

Indexed keywords

DOXORUBICIN; RHODAMINE;

ARTICLE; CELL DENSITY; CELL LINE; CONTROLLED STUDY; CYTOCHEMISTRY; CYTOTOXICITY; DRUG SCREENING; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL; TECHNIQUE;

CELL SURVIVAL; DOXORUBICIN; HUMANS; LEUKEMIA; RHODAMINES; TISSUE FIXATION; TUMOR CELLS, CULTURED;

EID: 0030293055     PISSN: 10568719     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8719(96)00113-X     Document Type: Article

References (14)

1. Alley MC, Scudiero DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH, Boyd MR (1988) Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 48: 589-601.
2. Braakhuis BJ, Jansen G, Noordhuis P, Kegel A, Peters GJ (1993) Importance of pharmacodynamics in the in vitro antiproliferative activity of the antifolates methotrexate and 10-ethyl-10-deazaamminopterin against human head and neck squamous cell carcinoma. Biochem Pharmacol 46: 2155-2161.
3. Boyd MR (1989) Status of the National Cancer Institute preclinical antitumor drug discovery screen. In Cancer, Principles and Practice of Oncology Update, Vol. 3, No. 10. Eds., VI Devita, Jr, S Hellman, and SA Rosenberg. Philadelphia: Lippincott. pp. 1-12.
4. Casciari JJ, Hollingshead MG, Alley MC, Mayo JG, Malspeis L, Miyauchi S, Grever M R, Weinstein JN (1994) Growth and chemotherapeutic response of cells in a hollow-fiber in vitro solid tumor model. J Natl Cancer Inst 86: 1846-1852.
5. Garbin F, Eckert K, Maurer HR (1994) Evaluation of the MTT and SRB assay for testing LAK cell mediated growth inhibition of various adherent and non-adherent tumor target cells. J Immunol Methods 170: 269-271.
6. Hixson LJ, Alberts DS, Krutzsch M, Einsphar J, Brendel K, Gross PH, Paranka NS, Baier M, Emerson S, Pamukcu R (1994) Antiproliferative effect of nonsteroidal antiinflammatory drugs against human colon cancer cells. Cancer Epidemiol Biomarkers Prev 3: 433-438.
7. Kelland LR, Mistry P, Abel G, Friedlos F, Loh SY, Roberts JJ, Harrap KR (1992a) Establishment and characterization of an in vitro model of acquired resistance to cisplatin in a human testicular nonseminomatous germ cell line. Cancer Res 52: 1710-1716.
8. Kelland LR, Jones M, Abel G, Valenti M, Gwynne J, Harrap KR (1992b) Human ovarian-carcinoma cell lines and companion xenograft: A disease-oriented approach to new platinum anticancer drug discovery. Cancer Chemother Pharmacol 30: 43-50.
9. Martin A, Cylines M (1993) Comparison of 5 microplate colorimetric assays for in vitro cytotoxicity testing and cell proliferation assay. Cytotechnology 11: 49-58.
10. Monks A, Scudiero D, Skehan P, Shoemaker R, Paull K, Vistica D, Hose C, Langley J, Cronise P, Vaigro-Wolff A, Goodrich MG, Campbell H, Mayo J, Boyd M (1991) Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J Natl Cancer Inst 83: 757-766.
11. Pizao PE, Smitskamp-Wilms E, Van Ark-Otte J, Beijnen JH, Peters GJ, Pinedo HM, Giaccone G (1994) Antiproliferative activity of the topoisimerase I inhibitor topotecan and camptothecin, on sub-and postconfluent tumor cell cultures. Biochem Pharmacol 48: 1145-1154.
12. Rubinstein LV, Shoemaker RH, Paull KD, Simon RM, Tosini S, Skehan P, Scudiero D A, Monks A, Boyd MR (1990) Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines. J Natl Cancer Inst 82: 1113-1118.
13. Skehan P, Storeng R, Scudiero D, Monks A, McMahan J, Vistica D, Warren JT, Bokesch H, Kenny S, Boyd MR (1990) New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82: 1107-1112.
14. Wu L, Smythe AM, Stinson SF, Mullendoro LA, Monks A, Scudiero DA, Paull KD, Koutsoukos AD, Rubinstein LV, Boyd MR, Shoemaker RH (1992) Multidrug-resistant phenotype of disease-oriented panels of human tumor cell lines used for anticancer drug screening. Cancer Res 52: 3029-3034.